[MDGL] YoY Quarter Result on 31-Dec-2012 [#Q4]

Stock
[MDGL] Madrigal Pharmaceuticals, Inc.
Announcement Date
14-Mar-2013
Financial Year
2012
Quarter
31-Dec-2012 [#Q4]
Profit Trend
QoQ- -20.85%
YoY- -68.70%
Quarter Report
MDGL's Result
MDGL's Financial Summary
View:
Show?
Quarter Result
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Revenue 0 0 0 7,437 3,423 4,037 4,680 -
PBT -10,536 -20,352 -24,162 -47,380 -47,380 -37,467 79,088 -
Tax 0 0 0 -44,667 -36,637 -28,644 86,125 -
NP -10,536 -20,352 -24,162 -18,123 -10,743 -8,823 -7,037 6.95%
Tax Rate - - - - - - -108.90% -
Total Cost 10,536 20,352 24,162 25,560 14,166 12,860 11,717 -1.75%
Ratio Analysis
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
NP Margin 0.00 0.00 0.00 -243.69 -313.85 -218.55 -150.36 -
Per Share
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
EPS -2.68 -6.57 -9.90 -9.19 -6.67 -7.48 -6.24 -13.13%
EPS Diluted -2.68 -6.57 -9.90 -9.19 -6.67 -7.35 -6.24 -13.13%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.